FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome

FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome Print this page May 06, 2019 — The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 years to less than 17 years of age. This is the first FDA approval of a… Read More »

Global Health: Where Will Measles Break Out Next? Chicago, Los Angeles or Miami, Scientists Predict

Chicago, Los Angeles and Miami are the cities most likely to see the next measles outbreaks, according to an unusual new study. Researchers at the University of Texas at Austin and Johns Hopkins University mapped the 25 American counties most at risk of measles because of their vaccine-exemption rates and proximity to airports. A similar… Read More »